Prokidney Corp (PROK)

$1.94 -0.06 (-3.00%)
Market Cap 603.83M
Revenue (ttm) 890,000.00
Net Income (ttm) -68.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7,751.69%
Debt to Equity Ratio 0.00
Volume 703,100
Avg Vol 835,276
Day's Range N/A - N/A
Shares Out 301.92M
Stochastic %K 18%
Beta 1.84
Analysts Sell
Price Target $5.50

Company Profile

ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes. It is also involved in the development of cryopreserved versions of rilparencel, including REGEN-006 and REGEN-008 which are both in...

Industry: Biotechnology
Sector: Healthcare
Phone: 336 999 7019
Address:
2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, United States
raqu001
raqu001 Apr. 24 at 4:45 AM
$PROK what’s the best way to vote for the 2026 annual meeting? Please provide reasons for each vote.
1 · Reply
wavridr
wavridr Apr. 14 at 7:12 PM
$PROK of course this POS is red on the greenest days 💩💩💩💩
0 · Reply
wavridr
wavridr Apr. 8 at 8:39 PM
$PROK 2 cents with Nasdaq +600 and Dow +1,300 💩💩💩💩💩💩
0 · Reply
Dkll303
Dkll303 Apr. 6 at 9:25 PM
$PROK $CADL …they share the same road map … Knock knock Who’s there ? Peter Petrie ! Peter Petrie who ? HMMMM …I got nothing !
0 · Reply
Traildog19
Traildog19 Apr. 4 at 3:37 AM
$PROK Dead $ until Q2/27. R/s ahead?
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 3 at 3:14 AM
$PROK RSI: 34.51, MACD: -0.1193 Vol: 0.27, MA20: 2.02, MA50: 2.07 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
DemsRuinBigCities
DemsRuinBigCities Apr. 2 at 8:39 PM
$PROK the day was red but yet this was up with decent volume. Hmm
1 · Reply
wavridr
wavridr Mar. 30 at 8:20 PM
$PROK a little green day before the next 5 red days 😂💩
0 · Reply
topstockalerts
topstockalerts Mar. 27 at 8:33 PM
After Hours Top Gainers PT2 $CREG $FBLG $PROK $VWAV $RANI
0 · Reply
wavridr
wavridr Mar. 27 at 5:58 PM
$PROK 8 more cents! Let's go! 🔨🔨🔨🔨🔨🔨🔨🔨
0 · Reply
Latest News on PROK
ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer

Mar 25, 2026, 4:01 PM EDT - 4 weeks ago

ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer

ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference

Jan 6, 2026, 7:30 AM EST - 3 months ago

ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference

ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

Nov 10, 2025, 4:15 PM EST - 5 months ago

ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025

Nov 6, 2025, 11:00 AM EST - 6 months ago

ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025

ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference

Oct 29, 2025, 7:30 AM EDT - 6 months ago

ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference

ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2025

Oct 20, 2025, 7:30 AM EDT - 6 months ago

ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2025

ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference

Aug 27, 2025, 7:30 AM EDT - 8 months ago

ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference

ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

Aug 12, 2025, 4:01 PM EDT - 9 months ago

ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel

Jul 15, 2025, 7:30 AM EDT - 10 months ago

ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel

Trump's latest tariff threats and the impact on markets, ProKidney stock jumps over 500%

Jul 9, 2025, 11:22 AM EDT - 10 months ago

Trump's latest tariff threats and the impact on markets, ProKidney stock jumps over 500%

ProKidney: What's Happening With PROK Stock?

Jul 9, 2025, 8:45 AM EDT - 10 months ago

ProKidney: What's Happening With PROK Stock?

ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

Jul 9, 2025, 7:30 AM EDT - 10 months ago

ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

ProKidney's stock rockets on ‘intriguing' news, but analyst doesn't recommend buying

Jul 8, 2025, 5:09 PM EDT - 10 months ago

ProKidney's stock rockets on ‘intriguing' news, but analyst doesn't recommend buying

Gold Falls 1%; ProKidney Shares Spike Higher

Jul 8, 2025, 1:25 PM EDT - 10 months ago

Gold Falls 1%; ProKidney Shares Spike Higher

Why Is Penny Stock ProKidney Trading Higher On Tuesday?

Jul 8, 2025, 9:05 AM EDT - 10 months ago

Why Is Penny Stock ProKidney Trading Higher On Tuesday?

ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes

Jul 8, 2025, 7:00 AM EDT - 10 months ago

ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes

ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware

Jul 1, 2025, 12:43 PM EDT - 10 months ago

ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware

ProKidney Reports First Quarter 2025 Financial Results and Business Highlights

May 12, 2025, 4:15 PM EDT - 1 year ago

ProKidney Reports First Quarter 2025 Financial Results and Business Highlights

ProKidney Reports Full Year 2024 Financial Results and Business Highlights

Mar 17, 2025, 7:30 AM EDT - 1 year ago

ProKidney Reports Full Year 2024 Financial Results and Business Highlights

Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm

Jan 31, 2025, 11:08 AM EST - 1 year ago

Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm

ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference

Nov 26, 2024, 7:30 AM EST - 1 year ago

ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference

ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting

Nov 12, 2024, 7:30 AM EST - 1 year ago

ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting

ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference

Nov 5, 2024, 7:30 AM EST - 1 year ago

ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference

ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024

Oct 14, 2024, 7:30 AM EDT - 1 year ago

ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024

ProKidney to Participate in the UBS Virtual Organ Restoration Day

Oct 9, 2024, 7:30 AM EDT - 1 year ago

ProKidney to Participate in the UBS Virtual Organ Restoration Day

ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel's Registrational Path to Potential Approval in the U.S.

Sep 3, 2024, 7:30 AM EDT - 1 year ago

ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel's Registrational Path to Potential Approval in the U.S.

ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 27, 2024, 7:30 AM EDT - 1 year ago

ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

ProKidney Reports Business Updates and Second Quarter 2024 Financial Results

Aug 9, 2024, 7:00 AM EDT - 1 year ago

ProKidney Reports Business Updates and Second Quarter 2024 Financial Results

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 11, 2024, 9:35 PM EDT - 2 years ago

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 10, 2024, 4:15 PM EDT - 2 years ago

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates

Jun 10, 2024, 6:30 AM EDT - 2 years ago

ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates

ProKidney to Participate in the Jefferies Global Healthcare Conference

May 29, 2024, 7:00 AM EDT - 2 years ago

ProKidney to Participate in the Jefferies Global Healthcare Conference

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024

May 21, 2024, 7:00 AM EDT - 2 years ago

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024

ProKidney Reports Business Updates and First Quarter 2024 Financial Results

May 10, 2024, 7:00 AM EDT - 2 years ago

ProKidney Reports Business Updates and First Quarter 2024 Financial Results

ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

Mar 25, 2024, 6:05 AM EDT - 2 years ago

ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

Mar 21, 2024, 7:49 PM EDT - 2 years ago

ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

ProKidney to Participate in Jefferies Biotech on the Bay Summit

Feb 29, 2024, 4:05 PM EST - 2 years ago

ProKidney to Participate in Jefferies Biotech on the Bay Summit

ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer

Nov 30, 2023, 6:05 AM EST - 2 years ago

ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer

ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference

Nov 21, 2023, 6:05 AM EST - 2 years ago

ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference

ProKidney Reports Third Quarter Financial Results

Nov 14, 2023, 6:05 AM EST - 2 years ago

ProKidney Reports Third Quarter Financial Results

ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates

Nov 13, 2023, 5:02 PM EST - 2 years ago

ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates

ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2023

Oct 30, 2023, 4:12 PM EDT - 2 years ago

ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2023

ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference

Sep 5, 2023, 6:05 AM EDT - 2 years ago

ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference

ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights

Aug 10, 2023, 4:10 PM EDT - 2 years ago

ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights

ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC

Jul 18, 2023, 6:05 AM EDT - 3 years ago

ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC

ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization

Jul 15, 2023, 2:02 AM EDT - 3 years ago

ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization

ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC

Jun 13, 2023, 12:05 PM EDT - 3 years ago

ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC

ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference

Jun 1, 2023, 4:05 PM EDT - 3 years ago

ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference

ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights

May 11, 2023, 4:01 PM EDT - 3 years ago

ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights

ProKidney to Present at the BofA Securities Health Care Conference 2023

May 4, 2023, 6:05 AM EDT - 3 years ago

ProKidney to Present at the BofA Securities Health Care Conference 2023

raqu001
raqu001 Apr. 24 at 4:45 AM
$PROK what’s the best way to vote for the 2026 annual meeting? Please provide reasons for each vote.
1 · Reply
wavridr
wavridr Apr. 14 at 7:12 PM
$PROK of course this POS is red on the greenest days 💩💩💩💩
0 · Reply
wavridr
wavridr Apr. 8 at 8:39 PM
$PROK 2 cents with Nasdaq +600 and Dow +1,300 💩💩💩💩💩💩
0 · Reply
Dkll303
Dkll303 Apr. 6 at 9:25 PM
$PROK $CADL …they share the same road map … Knock knock Who’s there ? Peter Petrie ! Peter Petrie who ? HMMMM …I got nothing !
0 · Reply
Traildog19
Traildog19 Apr. 4 at 3:37 AM
$PROK Dead $ until Q2/27. R/s ahead?
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 3 at 3:14 AM
$PROK RSI: 34.51, MACD: -0.1193 Vol: 0.27, MA20: 2.02, MA50: 2.07 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
DemsRuinBigCities
DemsRuinBigCities Apr. 2 at 8:39 PM
$PROK the day was red but yet this was up with decent volume. Hmm
1 · Reply
wavridr
wavridr Mar. 30 at 8:20 PM
$PROK a little green day before the next 5 red days 😂💩
0 · Reply
topstockalerts
topstockalerts Mar. 27 at 8:33 PM
After Hours Top Gainers PT2 $CREG $FBLG $PROK $VWAV $RANI
0 · Reply
wavridr
wavridr Mar. 27 at 5:58 PM
$PROK 8 more cents! Let's go! 🔨🔨🔨🔨🔨🔨🔨🔨
0 · Reply
wavridr
wavridr Mar. 27 at 4:45 PM
$PROK 🏄
0 · Reply
Biohacker
Biohacker Mar. 27 at 2:09 PM
$PROK RIP
0 · Reply
wavridr
wavridr Mar. 27 at 1:43 PM
$PROK 1.50 let's go! 🔨🔨🔨🔨🔨🔨🔨
0 · Reply
wavridr
wavridr Mar. 26 at 3:35 PM
$PROK next stop 1.50 🔨🔨🔨🏄
1 · Reply
wavridr
wavridr Mar. 24 at 4:42 PM
$PROK 1.50 by Friday 🔨🔨💩
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 24 at 2:30 PM
$PROK Q4 '25 Earnings Results & Recap ProKidney anticipates topline data readout for the surrogate endpoint (eGFR slope) in Q2 2027 and for the confirmatory endpoint in H2 2029, with existing cash sufficient until mid-2027.
0 · Reply
wavridr
wavridr Mar. 23 at 1:50 PM
$PROK markets up 2% and this POS is red! 🤣🤣🤣
0 · Reply
wavridr
wavridr Mar. 19 at 8:07 PM
$PROK 2.60 to 1.87 in 7 days 😂😂 Excellent! 1.70 tmrw 🔨🔨🔨💩
1 · Reply
Biohacker
Biohacker Mar. 19 at 1:46 PM
$PROK load zone
0 · Reply
Merlintrader
Merlintrader Mar. 19 at 10:57 AM
$PROK https://www.merlintrader.com/prokidney-fy2025-earnings/
0 · Reply
Biohacker
Biohacker Mar. 17 at 4:09 PM
$PROK reload below 2 then unload above 2.4 until data release Q2 2027 Not going anywhere until then .
1 · Reply
wavridr
wavridr Mar. 16 at 7:03 PM
$PROK keep going ⬇️ and stay down 💩💩💩
0 · Reply